Adam Koppel

Adam Koppel is a declared insider at 4 companies (board member); the most frequent names are Cerevel Therapeutics Holdings, Inc., Kailera Therapeutics, Inc. and Dicerna Pharmaceuticals Inc. We count 10 filings; the first trade dates from 3 June 2021 and the latest from 20 April 2026.

On the market, this insider has only ever bought: 2 purchases, €139.6M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 1 option exercise. Since January 2026: 1 purchase and no sales on the market.

The newest entry dates from 20 April 2026: a transaction, in Kailera Therapeutics, Inc. The last purchase on record was published on 20 April 2026, which is 181 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.